CaroGen Corporation Email Format

Biotechnology ResearchConnecticut, United States2-10 Employees

CaroGen Corporation is a privately held biotechnology company based in Farmington, Connecticut, focused on advancing vaccine science developed at Yale University School of Medicine. It holds an exclusive license with Yale University for a replication-proficient virus-like vesicle platform intended for the development and worldwide commercialization of vaccines. The technology has been validated in animal studies, including non-human primates, and is being used to create recombinant protein nanoparticle vaccines aimed at triggering immune protection against a range of pathogens.

The company's work targets infectious and chronic diseases, with programs including vaccines against hepatitis B and potential exploration of hepatitis C and other viral agents. CaroGen collaborates with research institutions such as the NIH for preclinical evaluation of AVIDIO-based influenza vaccine candidates, and in 2021 announced BioCentriq as its manufacturing partner for CARG-201, a potential functional cure for HBV.

Get verified CaroGen Corporation emails free

Company overview Employee directory